Wall Street brokerages predict that Humana Inc. (NYSE:HUM) will report earnings per share (EPS) of $3.26 for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Humana’s earnings, with the lowest EPS estimate coming in at $3.10 and the highest estimate coming in at $3.42. Humana reported earnings per share of $3.18 during the same quarter last year, which indicates a positive year over year growth rate of 2.5%. The business is expected to issue its next earnings results before the market opens on Wednesday, November 8th.

According to Zacks, analysts expect that Humana will report full year earnings of $11.57 per share for the current financial year, with EPS estimates ranging from $11.47 to $11.87. For the next financial year, analysts expect that the company will report earnings of $12.25 per share, with EPS estimates ranging from $11.95 to $12.97. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that that provide coverage for Humana.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The company had revenue of $13.53 billion for the quarter, compared to the consensus estimate of $13.61 billion. During the same period in the prior year, the firm posted $2.30 EPS.

A number of equities analysts have commented on HUM shares. ValuEngine upgraded shares of Humana from a “hold” rating to a “buy” rating in a report on Friday, September 1st. UBS AG reiterated a “neutral” rating and issued a $250.00 target price (up from $237.00) on shares of Humana in a report on Wednesday, August 9th. BidaskClub upgraded shares of Humana from a “sell” rating to a “hold” rating in a report on Thursday, August 10th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $223.00 target price (up from $200.00) on shares of Humana in a report on Thursday, August 3rd. Finally, Morgan Stanley boosted their target price on shares of Humana from $269.00 to $276.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Eleven analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $251.60.

In other news, VP Timothy S. Huval sold 7,803 shares of the company’s stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $258.14, for a total transaction of $2,014,266.42. Following the completion of the transaction, the vice president now directly owns 8,831 shares of the company’s stock, valued at approximately $2,279,634.34. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider William Kevin Fleming sold 3,071 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total value of $770,759.58. Following the transaction, the insider now directly owns 7,681 shares of the company’s stock, valued at $1,927,777.38. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 55,595 shares of company stock valued at $14,133,706. Corporate insiders own 0.80% of the company’s stock.

Several hedge funds have recently made changes to their positions in HUM. BlackRock Inc. raised its stake in shares of Humana by 2,281.7% during the 1st quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock worth $2,553,487,000 after buying an additional 11,867,056 shares during the period. Janus Henderson Group PLC raised its stake in shares of Humana by 7,848.8% during the 2nd quarter. Janus Henderson Group PLC now owns 1,567,587 shares of the insurance provider’s stock worth $377,192,000 after buying an additional 1,547,866 shares during the period. FMR LLC raised its stake in shares of Humana by 29.3% during the 2nd quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock worth $1,571,264,000 after buying an additional 1,479,210 shares during the period. Renaissance Technologies LLC raised its stake in shares of Humana by 84.3% during the 1st quarter. Renaissance Technologies LLC now owns 2,691,700 shares of the insurance provider’s stock worth $554,867,000 after buying an additional 1,231,400 shares during the period. Finally, AQR Capital Management LLC raised its stake in shares of Humana by 413.8% during the 1st quarter. AQR Capital Management LLC now owns 736,019 shares of the insurance provider’s stock worth $151,723,000 after buying an additional 592,772 shares during the period. 95.12% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Humana Inc. (HUM) Expected to Post Earnings of $3.26 Per Share” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/10/15/humana-inc-hum-expected-to-post-earnings-of-3-26-per-share.html.

Shares of Humana (NYSE:HUM) traded down 1.54% during mid-day trading on Friday, reaching $237.73. 812,079 shares of the company traded hands. The firm has a 50 day moving average of $247.41 and a 200-day moving average of $235.61. The stock has a market capitalization of $34.36 billion, a PE ratio of 19.56 and a beta of 0.86. Humana has a 52 week low of $165.03 and a 52 week high of $259.76.

The firm also recently announced a dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 29th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s payout ratio is 13.06%.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get a free copy of the Zacks research report on Humana (HUM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.